ClinicalTrials.govpublic full text
A Study to Assess the Safety, Pharmacokinetics, and Efficacy of Intravenous (IV) ABBV-303, as Monotherapy and in Combination With IV Infused Budigalimab (ABBV-181), in Adults With Advanced Solid Tumors
solid tumors, non-small cell lung cancer, nsclc, renal cell carcinoma, rcc, head and neck squamous cell carcinoma, hnscc, abbv-303, abbv-181, budigalimab, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 826788
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.